Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Rigolin, Gian Matteo
245  Ergebnisse:
Personensuche X
?
1

CAD204520 Targets NOTCH1 PEST Domain Mutations in Lymphopro..:

Pagliaro, Luca ; Cerretani, Elisa ; Vento, Federica...
International Journal of Molecular Sciences.  25 (2024)  2 - p. 766 , 2024
Link: https://doi.org/10.3390/..
 
?
2

Correction: Different prognostic impact of recurrent gene m..:

Mansouri, Larry ; Thorvaldsdottir, Birna ; Sutton, Lesley-Ann...
Leukemia.  37 (2023)  2 - p. 504-504 , 2023
Link: https://doi.org/10.1038/..
 
?
3

Continuous venetoclax in treatment‐naive TP53 disrupted pat..:

Visentin, Andrea ; Mauro, Francesca Romana ; Scarfò, Lydia...
American Journal of Hematology.  98 (2023)  9 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
4

Outcomes in patients with chronic lymphocytic leukemia and ..:

Rigolin, Gian Matteo ; Olimpieri, Pier Paolo ; Summa, Valentina...
Blood Cancer Journal.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
5

First-Line Treatment of Older Patients with CLL: A New Appr..:

Urso, Antonio ; Cavazzini, Francesco ; Ballardini, Maria Pia...
Cancers.  15 (2023)  15 - p. 3859 , 2023
Link: https://doi.org/10.3390/..
 
?
6

Additional lesions identified by genomic microarrays are as..:

Rigolin, Gian Matteo ; Traversa, Alice ; Caputo, Viviana...
British Journal of Haematology.  202 (2023)  5 - p. 953-959 , 2023
Link: https://doi.org/10.1111/..
 
?
7

High rate of durable responses with undetectable minimal re..:

Mauro, Francesca R. ; Starza, Irene Della ; Messina, Monica...
Haematologica.  108 (2023)  8 - p. 2091-2100 , 2023
Link: https://doi.org/10.3324/..
 
?
8

Lymphadenopathy as a predictor of progression during veneto..:

Autore, Francesco ; Innocenti, Idanna ; Reda, Gianluigi...
Hematological Oncology.  41 (2023)  5 - p. 877-883 , 2023
Link: https://doi.org/10.1002/..
 
?
9

Obinutuzumab plus chlorambucil versus ibrutinib in previous..:

Visentin, Andrea ; Mauro, Francesca Romana ; Catania, Gioachino...
Frontiers in Oncology.  12 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
10

Prediction of outcomes in chronic lymphocytic leukemia pati..:

Molica, Stefano ; Giannarelli, Diana ; Visentin, Andrea...
American Journal of Hematology.  97 (2022)  5 - p. , 2022
Link: https://doi.org/10.1002/..
 
?
11

Different prognostic impact of recurrent gene mutations in ..:

Mansouri, Larry ; Thorvaldsdottir, Birna ; Sutton, Lesley-Ann...
Leukemia.  37 (2022)  2 - p. 339-347 , 2022
Link: https://doi.org/10.1038/..
 
?
12

Association of IMWG frailty score with health-related quali..:

Efficace, Fabio ; Gaidano, Gianluca ; Petrucci, Maria Teresa...
The Lancet Healthy Longevity.  3 (2022)  9 - p. e628-e635 , 2022
Link: https://doi.org/10.1016/..
 
?
13

TP53 Abnormalities Are Underlying the Poor Outcome Associat..:

Ramos-Campoy, Silvia ; Puiggros, Anna ; Kamaso, Joanna...
Cancers.  14 (2022)  15 - p. 3715 , 2022
Link: https://doi.org/10.3390/..
 
?
14

Long‐term benefit of IGHV mutated patients in a real‐life m..:

Moia, Riccardo ; Dondolin, Riccardo ; De Propris, Maria Stefania...
Hematological Oncology.  41 (2022)  3 - p. 567-570 , 2022
Link: https://doi.org/10.1002/..
 
?
15

Old and New Drugs for Chronic Lymphocytic Leukemia: Lights ..:

Marchetti, Monia ; Vitale, Candida ; Rigolin, Gian Matteo...
Journal of Clinical Medicine.  11 (2022)  8 - p. 2076 , 2022
Link: https://doi.org/10.3390/..
 
1-15